Synodos for Schwannomatosis, an international consortium of clinicians and scientists from multiple disciplines, was launched at a full team meeting in Toronto, Canada on May 1, 2017. At the conclusion of this inaugural meeting, we met with the leaders of this exciting new consortium, who spoke candidly about the meeting, schwannomatosis research, and what is at stake for this important project.
Congratulations to Vice President Joe Biden and Dr. Jill Biden on the launch of the Biden Cancer Initiative, a new venture to make progress in cancer prevention, detection, treatment, and care. The Children’s Tumor Foundation was represented at the kick-off event on June 26th at the Alexandria Center for Life Science in New York City by Foundation President and Chief Scientific Officer Annette Bakker, PhD, and Vice President, Marketing and Communications Simon Vukelj. The Biden Cancer Initiative is being established to inject a sense of urgency into cancer research and care systems by developing and driving solutions that will accelerate progress in the cancer field.
The NF Research Initiative (NFRI) at Boston Children’s Hospital has two open requests for applications:
NF CONFERENCE TAKING PLACE AT THE RENAISSANCE HOTEL DOWNTOWN WASHINGTON, DC JUNE 10-13, 2017
WITH KEYNOTE SPEAKER GREG SIMON, DIRECTOR, BIDEN CANCER INITIATIVE
On May 1, 2017, an international consortium of clinicians and scientists from multiple disciplines met in Toronto, Canada to officially launch the Synodos for Schwannomatosis project. Led by Dr. Gelareh Zadeh from University of Toronto and Dr. Laura Papi from University of Florence, Italy, the project aims to perform an extensive molecular analysis of schwannomatosis tumor samples to identify new therapeutic targets, and advance the understanding and management of the disease, with special focus on pain.